OpenAI backs bills in US Congress on AI and biological weapon threats

OpenAI's lobbying efforts in the US Congress are a calculated move. The company is actively shaping future AI regulation, not merely reacting to it. This proactive stance aims to establish guardrails that could favor early, large-scale model developers like OpenAI. It also sets a precedent for how major AI players engage with policymakers globally.

For Asia, this US legislative push is a bellwether. Regulators in markets like Singapore, Japan, and South Korea watch US policy closely. They will likely consider similar frameworks for AI safety and bioweapon threat mitigation. This could accelerate the adoption of specific compliance standards for AI development across the region, impacting local startups and established tech firms.

The thing to watch is whether these US bills include provisions that inadvertently create barriers for smaller AI developers. Such measures could entrench the market position of well-resourced companies like OpenAI. This would make it harder for new Asian AI companies to compete on a global scale by 2028.